Vertex Pharmaceuticals (VRTX) Cash from Operations (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.77% |
| Dec 31, 2025 | -59.88% |
| Sep 30, 2025 | 15.68% |
| Jun 30, 2025 | 31.04% |
| Mar 31, 2025 | 40.08% |
| Dec 31, 2024 | -57.32% |
| Sep 30, 2024 | 136.49% |
| Jun 30, 2024 | -387.28% |
| Mar 31, 2024 | 456.95% |
| Dec 31, 2023 | -81.50% |
| Sep 30, 2023 | 11.81% |
| Jun 30, 2023 | 26.06% |
| Mar 31, 2023 | -16.55% |
| Dec 31, 2022 | 12.86% |
| Sep 30, 2022 | -16.17% |
| Jun 30, 2022 | 19.20% |
| Mar 31, 2022 | -3.90% |
| Dec 31, 2021 | 7.31% |
| Sep 30, 2021 | 564.30% |
| Jun 30, 2021 | -121.68% |
| Mar 31, 2021 | 87.38% |
| Dec 31, 2020 | -45.85% |
| Sep 30, 2020 | -12.59% |
| Jun 30, 2020 | 27.32% |
| Mar 31, 2020 | 82.90% |
| Dec 31, 2019 | 33.21% |
| Sep 30, 2019 | -27.81% |
| Jun 30, 2019 | 42.79% |
| Mar 31, 2019 | 3.24% |
| Dec 31, 2018 | -17.51% |
| Sep 30, 2018 | 18.54% |
| Jun 30, 2018 | 27.33% |
| Mar 31, 2018 | 11.05% |
| Dec 31, 2017 | 33.76% |
| Sep 30, 2017 | -6.37% |
| Jun 30, 2017 | -31.63% |
| Mar 31, 2017 | 83.59% |
| Dec 31, 2016 | 120.43% |
| Sep 30, 2016 | 60.69% |
| Jun 30, 2016 | 369.93% |
| Mar 31, 2016 | -151.94% |
| Dec 31, 2015 | 146.95% |
| Sep 30, 2015 | 43.71% |
| Jun 30, 2015 | 50.38% |
| Mar 31, 2015 | -22.25% |
| Dec 31, 2014 | -107.40% |
| Sep 30, 2014 | 31.48% |
| Jun 30, 2014 | 27.22% |
| Mar 31, 2014 | -989.53% |
| Dec 31, 2013 | 244.02% |
| Sep 30, 2013 | -1,380.04% |
| Jun 30, 2013 | 98.59% |
| Mar 31, 2013 | -262.18% |
| Dec 31, 2012 | -61.72% |
| Sep 30, 2012 | -10.51% |
| Jun 30, 2012 | 3,960.53% |
| Mar 31, 2012 | -99.42% |
| Dec 31, 2011 | 1,074.18% |
| Mar 31, 2011 | -12.36% |
| Dec 31, 2010 | -1.29% |
| Sep 30, 2010 | -50.61% |
| Jun 30, 2010 | 44.58% |
| Mar 31, 2010 | -91.99% |
| Dec 31, 2009 | -372.97% |
| Sep 30, 2009 | 81.68% |
| Jun 30, 2009 | 36.37% |